LOGIN  |  REGISTER
Chimerix

Dynatronics Schedules Conference Call to Report Results for First Quarter Fiscal Year 2024

October 26, 2023 | Last Trade: US$0.09 0.00 0.00

Eagan, Minnesota--(Newsfile Corp. - October 26, 2023) - Dynatronics Corporation (NASDAQ: DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its fiscal year first quarter ended September 30, 2023 on Thursday, November 9, 2023.

The company will subsequently hold a conference call, consisting of prepared remarks by management, and a question-and-answer session with analysts, at 11:00 AM ET on Thursday, November 9, 2023, to review its first quarter results.

Interested persons may access the live conference call by dialing 1-800-898-3989 and entering the passcode 1005804# (U.S./Canada callers) or by visiting this link https://www.confsolutions.ca/ILT?oss=7P1R8008983989 (international callers), using passcode 1005804#. It is recommended that participants call or login 10 minutes ahead of the scheduled start time to ensure proper connection. An audio replay will be available one hour after the live call until Midnight on December 9, 2023, by dialing 1-800-408-3053 and entering the passcode 6594208# (U.S./Canada callers) or visiting this link https://www.confsolutions.ca/ILT?oss=4P1R8004083053 (international callers).

About Dynatronics Corporation

Dynatronics is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The Company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™, among others. More information is available at www.dynatronics.com.

Contact:

Dynatronics Corporation
Investor Relations

This email address is being protected from spambots. You need JavaScript enabled to view it.

For additional information, please visit: www.dynatronics.com

Connect with Dynatronics on LinkedIn

 

Recursion

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page